3 completed, 1 withdrawn. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Withdrawn 1 |
Follow AZD-3043: new trials by email Literature Review of AZD-3043 trials Research Report on AZD-3043
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I, Single Centre, Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043 AZD3043 - Safety, Tolerability | Phase 1 | Withdrawn | AstraZeneca | 2010-03-01 | 2012-12-20 | |
| AZD Single Ascending Dose Study In Healthy Japanese Subjects AZD3043 - Healthy | Phase 1 | Completed | AstraZeneca | 72 | 2009-12-01 | 2010-12-10 |
| Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043 AZD3043 - Healthy | Phase 1 | Completed | AstraZeneca | 72 | 2009-09-01 | 2009-12-18 |
| Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD3043 AZD3043 - Healthy | Phase 1 | Completed | AstraZeneca | 53 | 2009-05-01 | 2009-08-28 |
AstraZeneca (4)
Sweden (2) · United Kingdom (1)
Johan Wemer (2) · Sigridur Kalman (2) · Stephen Kanes (2) · Brendan Smyth (1) · Darren Wilbraham (1) · Dr. Ulrike Lorch, MFPM FRCA (1)